Faecal Microbiota Transplantation for Patients With Diabetes Mellitus Type 1 and Severe Gastrointestinal Neuropathy (Fadigas)

NCT04749030 NA COMPLETED

A randomised, double-blinded and placebo-controlled intervention study. The study aim to evaluate the feasibility, safety and pilot-efficacy of faecal microbiota transplantation as a treatment of severe gastrointestinal neuropathy in patients with diabetes mellitus type 1.

Details

Lead sponsor	University of Aarhus
Phase	NA
Status	COMPLETED
Enrolment	20
Start date	Tue Jun 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Sun Oct 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Faecal Microbiota Transplantation (FMT)
• Diabetes Mellitus, Type 1
• Gastrointestinal Neuropathy

Interventions

• Faecal microbiota transplantation (FMT) capsules
• Placebo capsules

Countries

Denmark